About Sai Life Sciences
Sai Life Sciences is a company based in Hyderabad (India) founded in 1999. Sai Life Sciences has raised $112.18 million across 10 funding rounds from investors including Tata Capital, TPG and HBM Healthcare Investments. The company has 3,400 employees as of March 31, 2024. Sai Life Sciences operates in a competitive market with competitors including Acies Bio, Liverpool ChiroChem, SpiroChem, IRBM and Personal Chemistry, among others.
- Headquarter Hyderabad, India
- Employees 3400 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sai Life Sciences Ltd.
-
Annual Revenue
$198.52 M (USD)15.46as on Mar 31, 2025
-
Net Profit
$19.9 M (USD)105.45as on Mar 31, 2025
-
EBITDA
$48.46 M (USD)38.96as on Mar 31, 2025
-
Total Equity Funding
$112.18 M (USD)
in 10 rounds
-
Latest Funding Round
$1.14 M (USD), Angel Round
Jul 03, 2024
-
Investors
Tata Capital
& 14 more
-
Employee Count
3400
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sai Life Sciences
Sai Life Sciences is a publicly listed company on the NSE with ticker symbol SAILIFE in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Sai Life Sciences
Unlock access to complete
Unlock access to complete
Leadership Team
25 people
Human Resources and Administration
12 people
Sales and Marketing
10 people
Software Development Team
7 people
Assistant Team
6 people
Finance and Accounting
4 people
Deputy Team
3 people
Manager Team
3 people
Unlock access to complete
Funding Insights of Sai Life Sciences
Sai Life Sciences has successfully raised a total of $112.18M across 10 strategic funding rounds. The most recent funding activity was a Angel Round of $1.14 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sai Life Sciences
Sai Life Sciences has secured backing from 15 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Tata Capital, TPG and HBM Healthcare Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund of funds focused on pre-seed and seed-stage companies
|
Locked | Locked | Locked | |
|
Late-stage life sciences investments are managed via VC and PE.
|
Locked | Locked | Locked | |
|
Life sciences focused VC firm funding companies in the US and Europe
|
Locked | Locked | Locked |
Investor details for Sai Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sai Life Sciences
Investment portfolio details for Sai Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sai Life Sciences
Detailed financials for Sai Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sai Life Sciences Comparisons
Peer comparison for Sai Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sai Life Sciences
Sai Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acies Bio, Liverpool ChiroChem, SpiroChem, IRBM and Personal Chemistry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Small organic molecules are supplied for biotech and pharmaceutical R&D.
|
|
| Locked | Locked | Locked |
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
|
|
| Locked | Locked | Locked |
Integrated drug discovery and preclinical development services are provided.
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
Detailed competitors of Sai Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sai Life Sciences
Complete news archive for Sai Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sai Life Sciences
Sai Life Sciences was founded in 1999 and raised its 1st funding round 7 years after it was founded.
Sai Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Krishna Kanumuri is the current CEO of Sai Life Sciences.
Sai Life Sciences is a funded company, having raised a total of $112.18M across 10 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Sai Life Sciences is 3,400.
Annual revenue of Sai Life Sciences is $198.52M as on Mar 31, 2025.
Sai Life Sciences was founded in 1999 in Hyderabad, India, and operates in the pharmaceutical sector. Services in drug discovery, development, and manufacturing of complex small molecules are offered, including synthetic and medicinal chemistry, pre-clinical toxicology, and DMPK studies. CMC operations cover pre-formulation, analytical development, stability studies, lyophilization, liposome processes, and formulation development.
Sai Life Sciences's top competitors include Acies Bio, Liverpool ChiroChem and IRBM.
Yes, Sai Life Sciences is publicly traded on NSE under the ticker symbol SAILIFE.
Sai Life Sciences has 15 investors. Key investors include Tata Capital, TPG, HBM Healthcare Investments, Fred Cohen, and Jagdish V Dore.
The ticker symbol of Sai Life Sciences is SAILIFE on NSE.
The valuation of Sai Life Sciences is $563.73M as of Jul 2024.